The DOI matches its Crossref record.
Presence of mast cell precursors in peripheral blood of mice demonstrated by parabiosis
Abstract
The presence of mast cell precursors in peripheral blood was examined. The beige C57BL/6 (bgj/bgj, Chediak-Higashi syndrome) mouse was parabiosed with the normal C57BL/6 mouse. Mast cells containing giant granules and originating in the beige partner appeared in the normal parabiont. A comparable proportion of normal-mouse-type mast cells developed in the beige parabiont as well. In spite of the low radiosensitivity of mature mast cells, irradiation of the normal parabiont reduced the proportion of normal-mouse-type mast cells appearing in the beige partner. It was concluded, therefore, that the precursors of mast cells can migrate through the bloodstream.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings were the first indication that mast cells are indeed hematopoietic in nature.”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [24]
In the citing paper
“In contrast, mast cells loaded with heparin‐containing granules have been reported only at E14.5‐E15.5 in the murine and rat skin. 49 , 53 , 56”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [49]
In the citing paper
“Indeed, over a period of 4.5 months, only mast cells in the cecum, stomach, and spleen receive sizeable input from the parabiotic partner. 24”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [24]
In the citing paper
“In keeping with this, mast cell potential was identified in the extra‐embryonic yolk sac and fetal liver. 27 , 49 , 51”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [49]
In the citing paper
“However, BM contribution is equally limited in “shielded” chimeras, in which most of the body is protected from irradiation, 53 as well as in parabiotic animals that are not irradiated at all. 24”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [24]
In the citing paper
“Furthermore, mast cells with metachromatic granules can already be found in fetal tissues, that is, before the onset of BM hematopoiesis. 49 , 50”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [49]
Citations
Cited by
Sorted by citations
Are mast cells instrumental for fibrotic diseases?
Overed-Sayer, C., Rapley, L., Mustelin, T., & Clarke, D. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00174 · Cited by 105
Mast cell ontogeny: From fetal development to life‐long health and disease
Chia, S. L., Kapoor, S., Carvalho, C., Bajénoff, M., & Gentek, R. (2023) · Immunological Reviews · doi:10.1111/imr.13191 · Cited by 60
Metadata
- Authors
- Kitamura, Y., Hatanaka, K., Murakami, M., & Shibata, H.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1979-06-01
- Volume
- 53
- Issue
- 6
- Pages
- 1085-1088
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 52
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
